107 related articles for article (PubMed ID: 3524894)
1. Myocardial ischemia: platelet and thromboxane concentrations in cardiac lymph and the effects of ibuprofen and prostacyclin.
Michael LH; Hunt JR; Lewis RM; Entman ML
Circ Res; 1986 Jul; 59(1):49-55. PubMed ID: 3524894
[TBL] [Abstract][Full Text] [Related]
2. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
Siess W; Roth P; Weber PC
Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane B2 in cardiac lymph. Effect of superoxide dismutase and catalase during myocardial ischemia and reperfusion.
Michael LH; Zhang Z; Hartley CJ; Bolli R; Taylor AA; Entman ML
Circ Res; 1990 Apr; 66(4):1040-4. PubMed ID: 2317886
[TBL] [Abstract][Full Text] [Related]
4. Prostacyclin inhibits 5-hydroxytryptamine release but stimulates thromboxane synthesis during cardiopulmonary bypass.
Aznavoorian SA; Utsunomiya T; Krausz MM; Cohn LH; Shepro D; Hechtman HB
Prostaglandins; 1983 Apr; 25(4):557-70. PubMed ID: 6348886
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
Schrör K; Löbel P; Steinhagen-Thiessen E
Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819
[TBL] [Abstract][Full Text] [Related]
6. Prostacyclin prolongs viability of washed human platelets.
Blackwell GJ; Radomski M; Vargas JR; Moncada S
Biochim Biophys Acta; 1982 Sep; 718(1):60-5. PubMed ID: 6291622
[TBL] [Abstract][Full Text] [Related]
7. Comparative effect of ibuprofen on endothelial and platelet prostaglandin synthesis.
Parks WM; Hoak JC; Czervionke RL
J Pharmacol Exp Ther; 1981 Nov; 219(2):415-9. PubMed ID: 7026767
[TBL] [Abstract][Full Text] [Related]
8. Use of prostacyclin to inhibit activation of platelets during preparation of platelet concentrates.
Menitove JE; Frenzke M; Aster RH
Transfusion; 1984; 24(6):528-31. PubMed ID: 6390814
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of endogenous thromboxane synthesis by exogenous prostacyclin during endotoxemia in conscious sheep.
Flynn JT; Demling RH
Adv Shock Res; 1982; 7():199-207. PubMed ID: 6753534
[TBL] [Abstract][Full Text] [Related]
10. Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo.
Fitzgerald DJ; Wright F; FitzGerald GA
Circ Res; 1989 Jul; 65(1):83-94. PubMed ID: 2500270
[TBL] [Abstract][Full Text] [Related]
11. Effects of platelet aggregation and adenosine 3':5'-monophosphate on the synthesis of thromboxane B2 in human platelets.
Lindgren JA; Claesson HE; Kindahl H; Hammarström S
Adv Prostaglandin Thromboxane Res; 1980; 6():275-81. PubMed ID: 6247886
[No Abstract] [Full Text] [Related]
12. Limb ischemia-induced increase in permeability is mediated by leukocytes and leukotrienes.
Klausner JM; Paterson IS; Valeri CR; Shepro D; Hechtman HB
Ann Surg; 1988 Dec; 208(6):755-60. PubMed ID: 3196098
[TBL] [Abstract][Full Text] [Related]
13. Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Circulation; 1985 Dec; 72(6):1336-45. PubMed ID: 2933181
[TBL] [Abstract][Full Text] [Related]
14. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia.
Schmitz JM; Apprill PG; Buja LM; Willerson JT; Campbell WB
Circ Res; 1985 Aug; 57(2):223-31. PubMed ID: 3926340
[TBL] [Abstract][Full Text] [Related]
15. Low-dose PGI2 prevents monocrotaline-induced thromboxane production and lung injury.
Czer GT; Marsh J; Konopka R; Moser KM
J Appl Physiol (1985); 1986 Feb; 60(2):464-71. PubMed ID: 3081477
[TBL] [Abstract][Full Text] [Related]
16. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane formation by platelets and platelet sensitivity to prostacyclin in patients with acute myocardial infarction.
Strano A; Davi G; Traina M; Novo S; Raineri A
Thromb Haemost; 1981 Dec; 46(4):759. PubMed ID: 7036402
[No Abstract] [Full Text] [Related]
18. Effects of coronary ischemia on lung fluid balance in conscious sheep.
Toyofuku T; Kobayashi T; Kubo K; Koyama S; Kusama S
J Appl Physiol (1985); 1988 Aug; 65(2):617-24. PubMed ID: 3170413
[TBL] [Abstract][Full Text] [Related]
19. Adverse effects of prostacyclin used to perfuse isolated lung lobes.
Krausz MM; Utsunomiya T; Levine LL; Dunham B; Shepro D; Hechtman HB
Am J Physiol; 1982 May; 242(5):H745-50. PubMed ID: 7044149
[TBL] [Abstract][Full Text] [Related]
20. Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.
Aiken JW; Shebuski RJ; Miller OV; Gorman RR
J Pharmacol Exp Ther; 1981 Nov; 219(2):299-308. PubMed ID: 6270303
[No Abstract] [Full Text] [Related]
[Next] [New Search]
